(Q47315641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

review article

1 reference

title

Can the retina be used to diagnose and plot the progression of Alzheimer's disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

0 references

9 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

768-777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

Retinal microvascular structure and function in patients with risk factors of atherosclerosis and coronary artery disease.

6 April 2020

cites work

1 reference

Automatic segmentation of choroidal thickness in optical coherence tomography.

21 January 2018

1 reference

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study

21 January 2018

1 reference

Analysis of optic disk color changes in Alzheimer's disease: a potential new biomarker.

21 January 2018

1 reference

Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography

21 January 2018

1 reference

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

21 January 2018

1 reference

Retinal abnormalities in early Alzheimer's disease

21 January 2018

1 reference

Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease

21 January 2018

1 reference

Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

21 January 2018

1 reference

Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake

21 January 2018

1 reference

Microvascular network alterations in the retina of patients with Alzheimer's disease

21 January 2018

1 reference

Replication of a study of frequency analysis of the resting awake EEG in mild probable Alzheimer's disease.

21 January 2018

1 reference

Retinal assessment using optical coherence tomography

21 January 2018

1 reference

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity

21 January 2018

1 reference

Retinal manifestations of Alzheimer's disease

21 January 2018

1 reference

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease.

21 January 2018

1 reference

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

Retinal oximetry imaging in Alzheimer's disease.

21 January 2018

1 reference

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

21 January 2018

1 reference

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

21 January 2018

1 reference

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

21 January 2018

1 reference

Smooth pursuit dysfunction in Alzheimer's disease.

21 January 2018

1 reference

The cholinergic hypothesis of Alzheimer's disease: a review of progress

21 January 2018

1 reference

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.

21 January 2018

1 reference

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

Macular thickness as a potential biomarker of mild Alzheimer's disease.

21 January 2018

1 reference

Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence

21 January 2018

1 reference

Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation

21 January 2018

1 reference

Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention

21 January 2018

1 reference

New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans.

21 January 2018

1 reference

A hundred years of Alzheimer's disease research

21 January 2018

1 reference

Ocular biomarkers of Alzheimer's disease.

21 January 2018

1 reference

Identifying and validating biomarkers for Alzheimer's disease

21 January 2018

1 reference

Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease

21 January 2018

1 reference

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease

21 January 2018

1 reference

Interconnection between brain and retinal neurodegenerations

21 January 2018

1 reference

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

21 January 2018

1 reference

Retinal vascular caliber and risk of dementia: the Rotterdam study

21 January 2018

1 reference

Prefrontal cortex and executive function impairments in primary breast cancer

21 January 2018

1 reference

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

21 January 2018

1 reference

Stereological Evaluation of the Optic Nerve Volume in Alzheimer Disease

21 January 2018

1 reference

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

21 January 2018

1 reference

Systemic associations of dynamic retinal vessel analysis: a review of current literature

21 January 2018

1 reference

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

21 January 2018

1 reference

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

21 January 2018

1 reference

Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.

21 January 2018

1 reference

Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography

21 January 2018

1 reference

A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease

21 January 2018

1 reference

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

21 January 2018

1 reference

Amyloid imaging in early detection of Alzheimer's disease

21 January 2018

1 reference

Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease.

21 January 2018

1 reference

Biomarkers of neurodegenerative disorders: how good are they?

21 January 2018

1 reference

Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits

21 January 2018

1 reference

Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility

21 January 2018

1 reference

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers

21 January 2018

1 reference

A potential role of the curry spice curcumin in Alzheimer's disease

21 January 2018

1 reference

Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints

21 January 2018

1 reference

Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging

21 January 2018

1 reference

Amyloid oligomers: formation and toxicity of Abeta oligomers

21 January 2018

1 reference

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons

21 January 2018

1 reference

Detection of retinal nerve fibre layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers.

21 January 2018

1 reference

Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.

21 January 2018

1 reference

Brain parenchymal and microvascular amyloid in Alzheimer's disease

21 January 2018

1 reference

Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

21 January 2018

1 reference

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke

21 January 2018

1 reference

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment

21 January 2018

1 reference

Smooth-pursuit eye movements: alterations in Alzheimer's disease

21 January 2018

1 reference

Assessment of choroidal thickness in healthy and glaucomatous eyes using swept source optical coherence tomography

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AOS.13472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29220126%20AND%20SRC:MED&resulttype=core&format=json